Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

European Journal of Nuclear Medicine

Volumn 27, Issue 12, 2000, Pages 1778-1785

  Higashi, Kotaro ^a   Ueda, Yoshimichi ^a   Sakurai, Aya ^a   MingWang, Xiao ^a   Xu, Linfeng ^a   Murakami, Manabu ^a   Seki, Hiroyasu ^b   Oguchi, Manabu ^a   Taki, Suzuka ^a   Nambu, Yoshihiro ^a   Tonami, Hisao ^a   Katsuda, Shogo ^a   Yamamoto, Itaru ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

Author keywords

Fluorine 18 fluorodeoxyglucose; Glucose transporter; Lung cancer; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOREACTIVITY; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; BRONCHIAL NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; PARAFFIN EMBEDDING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033637526     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000367     Document Type: Article

References (39)

1. Positron emission tomography: Applications in oncology
2. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET
3. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer
4. Fluorine-18-FDG imaging is negative in bronchioloalveolar lung carcinoma
5. Localized form of bronchioloalveolar carcinoma: FDG PET findings
6. Bronchioloalveolar carcinoma: Focal area of ground-glass attenuation at thin-section CT as an early sign
7. Tumor growth rate and its relationship to prognosis in bronchiolo-alveolar and pulmonary adenocarcinoma
8. FDG PET measurement of the proliferative potential of non-small cell lung cancer
9. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
10. Sequence and structure of a human glucose transporter
11. Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between Glut-1 expression and FDG uptake
12. Wide expression of the human erythrocyte glucose transporter Glut 1 in human cancers
13. Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia. NMR studies of living cells
14. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors
15. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study
16. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma
17. Procedure guideline for tumor imaging using fluorine-18-FDG
18. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival
19. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features
20. The changing pattern of lung carcinoma
21. Tumor growth rate and its relationship to prognosis in bronchiolo-alveolar and pulmonary adenocarcinoma
22. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma
23. Small adenocarcinoma of the lung
24. Expression of facilitative glucose transporter isoforms in lung carcinomas: Its relation to histologic type, differentiation grade, and tumor stage
25. Glucose transporter expression in developing fetal lung and lung neoplasms
26. Growth factors, mitogens, oncogenes, and the regulation of glucose transport
27. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia
28. Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells
29. Applicability of Tc-99m HL91, a putative hypoxic tracer, to detection of tumor hypoxia
30. Blood flow, oxygen and nutrient supply, and metallic microenvironment of human tumors: A review
31. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers
32. Glucose-transporter-type-gene amplification correlates with sialyl-lewis-X synthesis and proliferation in lung cancer
33. Facilitative glucose transporters
34. Aberrant glycolytic metabolism of cancer cell: A remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase
35. The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro
36. Mechanisms related to [F-18] fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice
37. Glut-1 and hexokinase expression: Relation with 2-fluoro-2deoxy-D-glucose uptake in A431 and T47D cells in culture
38. Untreated primary lung and breast cancers: Correlation between F-18 FDG kinetic rate constants and findings of in vitro studies
39. 3H-2-deoxyglucose retention in murine tumor models